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ABSTRACT 
 
Objective: The etiology of lung injury following cardiopulmonary bypass (CPB) is 
multifactorial. Our study focused on quantifying the lactate release from the lungs precipitated by 
extracorporeal circulation at different time points after the insult. This was complemented by an 
evaluation of the gas exchange at the level of the alveolar-capillary membrane. 
Methods: Forty consecutive patients (age 61 ± 11 yrs, EUROScore 4.7 ± 2.7) undergoing CABG 
were prospectively analyzed. The data are presented as medians and the interquartile range. 
Results: The pulmonary lactate release (PLR) increased from a baseline value of 0.033 [range -
0.077 to 0.170] to 0.465 [range 0.113 to 0.922] mmol/min/m2, which was seen 6 hours 
postoperatively (P < 0.001). The A-a O2 gradient increased from 12.7 [range 8.8 to 15] to 39.1 
kPa [range 30.3 to 46.5] upon discontinuation of CPB (P < 0.001). The systemic arterial lactate 
(LS) concentration increased from 1.22 [range 1 to 1.44] to 3.03 [range 2.29 to 4.76] mmol/L six 
hours after surgery (P < 0.001). The venoarterial pCO2 difference (V-A dpCO2) rose from 0.6 
[range 0.5 to 0.9] to 0.9 [range 0.7 to 1] kPa (P = 0.014). The mortality in the studied group was 
5% (2/40).  
Conclusions: The lungs were found to be a significant source of lactate, and this pulmonary 
lactate flux was accentuated by CPB. The PLR correlated with systemic hyperlactatemia as well 
as the A-a O2 gradient, and was found to be higher in patients requiring prolonged mechanical 
ventilatory support. The duration of CPB had a significant impact on the systemic lactate 
concentrations, V-A dpCO2, and the A-a O2 gradient, but not on the PLR.  
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INTRODUCTION 
 
Pulmonary dysfunction after cardiac surgery remains a frequent problem that may have a 
profound influence upon patient recovery. The wide spectrum of manifestations ranges from mild 
subclinical dysfunction to full-blown adult respiratory distress syndrome [1]. 
Multiple factors may precipitate acute lung injury following cardiopulmonary bypass, but the 
systemic inflammatory response is likely one of the most prominent causes [2]. Preoperative 
factors affecting the evolution of postoperative pulmonary dysfunction are chronic obstructive 
pulmonary disease, smoking and respiratory muscle wasting. Multiple features of the surgical 
procedure employing cardiopulmonary bypass harbor the potential to precipitate pulmonary 
injury. Hemodilution, reduction in the plasma oncotic pressure and left atrial pressure elevation 
associated with weaning from cardiopulmonary bypass (CPB) contribute to the accumulation of 
fluid in the lung interstitium [3,4]. The lungs are not immune to the effects of cytotoxic 
mediators, emboli or reperfusion injury induced by CPB. Furthermore, lung perfusion is altered in 
a way that it is solely dependant upon bronchial circulation, since the flow through the pulmonary 
artery is virtually nonexistent. The complex disruption of pulmonary homeostasis may be further 
enhanced by ventilator associated lung injury.  
The pulmonary dysfunction may manifest itself by a widening of the alveolar-arterial  
oxygen gradient (A-a O2 gradient), increase in pulmonary vascular resistance (PVR) or changes 
in the pulmonary shunt [2]. The most malignant form of CPB induced pulmonary dysfunction is 
the adult respiratory distress syndrome (ARDS). The incidence of ARDS following cardiac 
surgery is below 2% [1,5,6].  
Serum lactate concentrations have been used as markers of systemic hypoperfusion in a variety of 
clinical settings, including the cardiac surgical patient population [7,8,9,10,11]. The etiology of 
hyperlactatemia following cardiopulmonary bypass, however, remains controversial. While the 
pathogenesis of type A lactic acidosis is unequivocally linked to hypoperfusion, type B lactic 
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acidosis, which occurs in patients in whom oxygen delivery is not impaired, may also 
occasionally be seen in patients undergoing CPB [12,13]. The lungs have previously been shown 
to be a source of lactate in the setting of lung injury, thereby producing a positive transpulmonary 
lactate gradient [14]. The venoarterial difference in the partial pressure of carbon dioxide (V-A 
dpCO2) has been instrumental in demonstrating hypoperfusion in several published studies 
[15,16].  
Our study aimed to test the hypothesis that cardiopulmonary bypass will have a significant impact 
on the pulmonary production of lactic acid, as well as compromise the functional integrity of the 
alveolar-capillary membrane. Furthermore, the pulmonary lactate release and the A-a oxygen 
gradient were documented at different time points in relation to the surgical insult in order to 
provide a chronological insight into the evolution of these markers of lung injury.  
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PATIENTS AND METHODS 
 
Following the approval from our institutional ethics committee, 40 consecutive patients 
undergoing coronary artery bypass grafting using cardiopulmonary bypass (CABG) were enrolled 
into our study. Informed consent was obtained from all patients. The study was conducted in a 
prospective observational fashion. Exclusion criteria were concomitant valvular pathology 
requiring surgery and reoperative surgical myocardial revascularization. 
 
Perioperative management 
The patients received diazepam and morphine 30 minutes prior to induction of anesthesia. 
Endotracheal tube, urinary catheter, as well as radial artery and pulmonary artery catheters were 
inserted. The anesthetic regime included induction and maintenance of anesthesia with 
midazolam, fentanyl and pancuronium bromide. This was coupled with sevoflurane inhalation. 
The initial ventilator settings included a tidal volume of 8 ml/kg, and a respiratory rate of 12 
breaths per minute. Typically, the FiO2 was set at 50%. The critical components of the employed 
cardiopulmonary circuit were the Medtronic Affinity Trillium membrane oxygenator, venous 
reservoir and PVC tubing (Medtronic, Minneapolis, USA) and a Stoeckert III roller pump 
(Stoeckert, Munich, Germany). Systemic heparinization aiming at an ACT > 480 seconds was 
used, followed by full reversal with protamine after decannulation. Tepid CPB was employed, 
targeting the flow at 2.2 L/min/m2. The target mean arterial pressure during CPB was 60 mmHg. 
If necessary, norepinephrine was employed to reach the aimed blood pressure. The surgical 
myocardial revascularization was performed on an arrested heart, during a period of aortic cross-
clamping. The lungs were open to atmosphere during CPB. Weaning from CPB was initiated 
once the patient’s rhythm had stabilized and normothermia had been achieved. Inotropic support 
was initiated in order to maintain a cardiac index greater than 2.2 L/min/m2.  The preferred 
inotropic agent was dobutamine. Norepinephrine was 
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vasodilatation. Epinephrine was used if the hemodynamic performance remained inadequate with 
the previously mentioned catecholamines. An intraaortic ballon pump was inserted if further 
support was required. 
 
Measurement and Calculations 
The study protocol consisted of obtaining arterial blood gas samples from the radial artery and 
mixed venous blood samples from the distal port of the pulmonary artery catheter. 
Thermodilution cardiac indices were obtained in triplicate and then averaged. The blood samples 
from the radial and pulmonary arteries were drawn simultaneously. The first sampling of radial 
and pulmonary arterial blood was performed upon induction of anesthesia and prior to the 
surgical incision (T1). Values obtained from the preoperative sampling and the results thus 
obtained, were used as control values. The second sample (T2) was taken intraoperatively, upon 
discontinuation of cardiopulmonary bypass and resumption of intrinsic cardiac and pulmonary 
function. The third (T3) and fourth (T4) samples were drawn in the intensive care unit 6 and 18 
hours after surgery, respectively. Thermodilution cardiac indices were obtained at all of the above 
mentioned stages of blood sampling. The raw data was then processed to obtain the 
transpulmonary lactate gradient and the pulmonary lactate release from the following formulas: 
TPLG = Lactate RA-Lactate PA – ((HbRA – HbPA)/HbRA)xLactate RA 
PLR = TPLGxCI 
 
 
CI = cardiac index HbPA = pulmonary artery hemoglobin 
HbRA = radial artery hemoglobin 
Lactate
 PA = lactate concentration in the 
pulmonary artery 
Lactate RA  = lactate concentration in the radial 
artery 
PLR= Pulmonary lactate release 
TPLG= Transpulmonary lactate gradient 
 
 
The effects of hemodilution were taken into account in order to obtain a hemoglobin adjusted 
pulmonary lactate release as was suggested by Kellum et al [14]. The A-a oxygen gradient was 
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obtained by subtracting the partial pressure of oxygen in arterial blood from the calculated 
alveolar oxygen tension [17]. The formulas for calculating the A-a oxygen gradient are shown 
here: 
A-a O2 gradient = PAO2 – PaO2 
PAO2 = PiO2 - PACO2/R 
PiO2 = (PB – PH2O) x FiO2 
 
A-a O2 gradient = Alveolar arterial oxygen 
gradient 
PAO2  = Alveolar oxygen tension 
PaO2 = Partial pressure of oxygen in arterial 
blood 
PiO2 = Partial pressure of inspired oxygen 
PACO2 = Alveolar carbon dioxide  tension 
(assumed to equal the partial pressure of CO2 in 
arterial blood due to the ease of exchange of 
CO2) 
R = Respiratory quotient (assumed at 0.8) 
PB = Barometric pressure 
PH2O = Water pressure (6.2 kPa as inspired air is 
fully saturated at the level of the carina) 
FiO2 = Fractional concentration of inspired 
oxygen 
 
One sample of arterial blood was analyzed at any given time point to obtain the A-a oxygen 
gradient. Individual A-a oxygen gradients were recorded for every patient at every time point. 
The data from all of the patients were then pooled and analyzed in order to obtain median values 
for the whole cohort at every preset time point (T1-T4). The initial FiO2 was 0.5 for the samples 
taken prior to the surgical incision. The subsequent fraction of inspired oxygen was dictated by 
each patient’s present partial pressure of oxygen in arterial blood. This value of FiO2 was then 
incorporated into the calculation for the corresponding A-a oxygen gradient. Only one FiO2 value 
was used for one time point, i.e. no attempt to investigate the effects of different ventilation 
settings on the A-a oxygen gradient was made.  
The venoarterial pCO2 difference was obtained by subtracting the partial pressure of CO2 in radial 
arterial blood from the partial CO2 pressure measured in the pulmonary artery. 
 
Statistical analysis 
The data are presented as mean values ± standard deviation or medians followed by the 
interquartile range for variables with a distribution that is not normal. Longitudinal comparisons 
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between samples of the same subject were analyzed using the ANOVA test. Correlations were 
analyzed using the nonparametric Spearman R correlation methodology. Analyses between 
different groups of patients were performed using the Mann-Whitney U test. A P < 0.05 was 
considered to be of statistical significance. The data were processed using the Statistica software 
package (StatSoft Inc., Tulsa, USA). 
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RESULTS 
 
Perioperative summary 
Forty consecutive patients undergoing coronary artery bypass grafting (CABG) were enrolled 
into our study. The patient demographic data are presented in Table 1. The spectrum of 
comorbidities seen in our patient population is typical for the contemporary cardiac surgical 
practice.  
The patient population profile included both elective and non-elective cases. There were four 
patients in whom the operation was performed on an emergent basis, related to complications of 
percutaneous coronary interventions. All of these had acute coronary syndromes noted prior to 
surgery. Two of these patients were found to be in significant hemodynamic compromise when 
referred to our tertiary care center from outside hospitals. Two patients had intraaortic balloon 
pumps placed preoperatively. The mortality was 5% (2/40). One of these patients died due to left 
ventricular free wall rupture on postoperative day 14, whereas the second death in this cohort was 
stroke related. The perioperative summary is presented in Table 2.  
The median values of the pulmonary lactate release increased from a baseline value of 0.033 
[range -0.077 to 0.170] to 0.465 [range 0.113 to 0.922] observed at six hours after surgery (P < 
0.001). The transpulmonary lactate gradient (TPLG) increased from the preoperative 0.014 [range 
-0.034 to 0.085] to 0.163 [range 0.041 to 0.249] mmol/L calculated from the samples taken 6 
hours after surgery (P = 0.001). 
The A-a O2 gradient increased from a baseline value of 12.7 [range 8.8 to 15] to 39.1 kPa [range 
30.3 to 46.5], immediately upon discontinuation of cardiopulmonary bypass (P < 0.001). The 
total arterial lactate content measured in the radial artery increased from 1.22 [range 1 to 1.44] to 
3.03 [range 2.29 to 4.76] mmol/L at 6 hours postoperatively (P < 0.001). The serum lactate 
concentration did not reach preoperative values by the end of the study protocol. A rise in the 
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venoarterial pCO2 gradient (V-A dpCO2) from 0.6 [range 0.5 to 0.9] to 0.9 [range 0.7 to 1] kPa at 
6 hours postoperatively was also found to be statistically significant (P = 0.014). This peak 
corresponded to the simultaneous peak in the systemic lactate concentration. There was no 
statistical significance to the dynamics of the pulmonary vascular resistance throughout the 
studied period. The evolution of the pulmonary lactate flux, transpulmonary lactate gradient, A-a 
O2 gradient, total arterial lactate, venoarterial pCO2 difference and PVR from the values obtained 
prior to CPB to those found at 18 hours postoperatively are presented in more detail in Table 3.  
 
Clinical correlations 
The amplification of the pulmonary lactate release correlated with the simultaneously observed 
increase in the systemic arterial lactate concentration at 6 (T3) hours after surgery. The PLR 
calculated from samples immediately upon discontinuation of CPB (T2) correlated with the 
appropriate A-a O2 gradient. The peak PLR also correlated with the A-a O2 gradient observed at 
18 hours after surgery. The PLRT4 correlated with the venoarterial pCO2 difference, which served 
as another index of systemic hypoperfusion. A lower A-a O2 gradient prior to surgery was 
predictive of quicker extubation. The alveolar-arterial oxygen gradient seen at 18 hours correlated 
with the duration of cardiopulmonary bypass. The A-a oxygen gradient T4 correlated with the 
corresponding pHT4 in addition to having an inverse correlation with the partial pressure of 
carbon dioxide in arterial blood sampled at the same time (T4). The peak increase in the systemic 
arterial lactate concentration (T3) correlated with the duration of CPB as well as the duration of 
mechanical ventilation. Additionally, the duration of CPB influenced the PVR and V-A dpCO2 at 
18 hours after CABG.  The correlations between the above noted measurements and clinical 
parameters are presented in greater detail in Table 4.  
The subgroup of patients in whom mechanical ventilation for more than 72 hours was required 
had a higher pulmonary lactate release 6 hours after surgery in comparison to patients weaned 
from the ventilator before that time (5.15 [range 0.991 to 5.956] vs. 0.392 [range 0.096 to 0.766] 
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mmol/min/m2, Mann-Whitney U test P = 0.005). Additionally, this subgroup of patients had 
higher A-a O2 gradients at 18 hours after surgery (32.5 [range 24.1 to 33.5] vs. 17.6 [range 11.3 to 
20.5], P < 0.001), higher serum lactate concentrations at T3 and T4 (13.63 [range 8.36 to 15.4] 
vs. 2.85 [range 2.27 to 4.04] mmol/L, P < 0.001, and 7.42 [range 4.26 to 8.2] vs. 1.97 [range 1.3 
to 2.71] mmol/L, P < 0.001, respectively) as well as higher pulmonary vascular resistance 6 hours 
after surgery (172 [range 121 to 200] vs. 92 [range 65 to 123] dyneּsec/cm5, P = 0.048). Higher 
EUROScore and CPB times were also noted in patients requiring prolonged ventilatory support 
(9±1 vs. 4.4±2.5, P = 0.008, and 105±37 vs. 66±26 min, P = 0.035). Patients in whom an 
intraaortic balloon pump was inserted had higher peak lactate levels (8.73 [range 5.28 to 15.4] vs. 
2.85 [range 2.27 to 4.04], P = 0.005). 
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 DISCUSSION 
 
The genesis of respiratory complications following cardiac surgery is complex and may stem 
from inherent pulmonary disease, depressed cardiac function with resultant pulmonary edema, 
post-perfusion inflammatory response or inadequate diaphragmatic function associated with 
phrenic nerve injury [2,5].  The functional and clinical changes have been corroborated by 
histological evidence of lung injury consisting of alveolar edema, extravasation of red blood cells 
and neutrophils as well as necrosis and swelling of pneumocytes and endothelial cells [1]. 
Cardiopulmonary bypass is responsible for the production and release of a plethora of markers, 
which serve to quantify both local organ dysfunctions and systemic perfusion aberrancies.  
Our study focused on the lactate release from the lungs and the dysfunction at the level of the 
alveolar-capillary membrane precipitated by extracorporeal circulation in patients undergoing 
surgical myocardial revascularization. In addition, we looked at systemic hypoperfusion indices, 
such as systemic lactate concentration and veno-arterial pCO2 gradient, and their correlation to 
cardiopulmonary bypass.  
We have demonstrated a modest pulmonary lactate production in our patient population even at 
baseline, i.e. the lungs were a source of lactate even in the absence of a notable surgical insult. 
The pulmonary lactate contribution rose significantly upon exposure to surgical trauma and 
cardiopulmonary bypass. The occurrence of a positive transpulmonary lactate gradient after CPB 
has been corroborated by other authors [14,18]. 
The values continued to rise up to six hours after the procedure, implying that the lactate washout 
from the lungs may be a protracted process.  The clinical impact of the pulmonary lactate release 
was illustrated in its correlation with the need for prolonged mechanical ventilatory support. 
There was no correlation between the PLR and the duration of CPB. While the lactate produced 
in the lungs was not the sole factor responsible for systemic hyperlactatemia, it significantly 
contributed to the systemic arterial lactate content measured at six after the procedure. The 
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dramatic augmentation of the alveolar-arterial oxygen gradient after surgery may corroborate the 
hypothesis that cardiopulmonary bypass caused a complex disturbance at the level of the 
alveolar-capillary membrane. One must recognize, however, that the presence of atelectasis after 
resumption of ventilation may have also contributed to this finding. Persistent widening of the 
alveolar-arterial O2 gradient was indicative of the requirement for prolonged mechanical 
ventilation. We were able to show a statistically significant correlation between the A-a O2 
gradient and the PLR after weaning from CPB. Arterial hyperlactatemia reflects the undesirable 
effects of CPB at the systemic level. We have demonstrated a correlation of the peak systemic 
lactate concentration with the duration of CPB and mechanical ventilation. Not surprisingly, 
patients in whom an intraaortic balloon pump for mechanical circulatory support was inserted had 
higher peak lactate levels. One should not neglect the possible confounding effect of 
catecholamine administration on the observed hyperlactatemia. Surprisingly, however, we found 
no statistically significant correlation between the use of inotropic support and systemic lactate 
concentrations. The evidence of global hypoperfusion during CPB in our study also included 
widening of the difference between the mixed venous and arterial pCO2 difference. The V-A 
dpCO2 correlated with the duration of CPB.  
We did not maintain pulmonary artery (PA) perfusion during cardiopulmonary bypass in our 
patients, nor were the lungs ventilated. Maintaining physiologic pulmonary perfusion has been 
advocated by some authors, in order to preserve the pulmonary clearance of certain 
proinflammatory cytokines [1]. The PA perfusion strategy has been linked to superior 
postoperative respiratory function in certain clinical scenarios, possibly due to attenuation of the 
ischemia-reperfusion injury, but has yet to gain wider acceptance [19,20]. The higher mortality 
and morbidity seen in our cohort is secondary to the patient profile referred to our center which 
accepts patients suffering from various complications from smaller regional hospitals, and is also 
reflective of the prospective nature of this study. Four patients in this cohort were referred for 
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surgery suffering from various degrees of myocardial ischemia and hemodynamic compromise 
due to either failed PCI in the setting of an acute coronary syndrome or complications thereof.  
There are certain limitations in this study that warrant mentioning. The pulmonary lactate release 
was calculated from the lactate gradient between the afferent and efferent circulations in relation 
to the lungs. The efferent sample, however, was not taken from the pulmonary veins, but rather 
from the radial artery. Theoretical concern could therefore be raised whether shunting through 
Thebesian veins could compromise the validity of the data. This issue, however, has been 
addressed in the past and the mixed venous sample has been utilized for quantification of the 
pulmonary lactate production in several studies [14,18,21]. Additionally, the sample size is 
relatively small; with the subgroup of patients requiring prolonged ventilatory support smaller 
still.  
In summary, our study is the first to offer a chronological perspective on the pulmonary lactate 
release after cardiopulmonary bypass in a relatively homogenous population of patients. The 
main findings of this study are that the pulmonary lactate release is accentuated by the surgical 
procedure employing cardiopulmonary bypass and that a higher PLR is predictive of prolonged 
mechanical ventilation. It also showed a correlation between the PLR and the disturbance at the 
level of the alveolar-capillary membrane, as well as the impact of pulmonary lactate production 
on systemic hyperlactatemia. While there is no doubt that cardiopulmonary bypass induces a 
violent disturbance of the normal cardiovascular physiology, one should not rush to condemn it as 
the sole etiologic factor responsible for the development of pulmonary dysfunction. One must 
also stress that the amplitude of pulmonary lactate production in our study is much less 
pronounced than that observed in patients with profound respiratory insufficiency documented in 
another study encompassing a wide range of etiologies [14].  
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Table 1. Preoperative patient characteristics 
 
Age (yrs) 61 ± 11 
Gender (n/%)  
    Male 34 (85) 
    Female 6 (15) 
EUROScore 4.7 ± 2.7 
Ejection fraction 53 ± 10 
Hypelipidemia (n/%) 18 (45) 
Hypertension (n/%) 28 (70) 
Diabetes mellitus (n/%) 10 (25) 
Smoking history (n/%) 16 (40) 
Preop. AMI (n/%) 21 (53) 
Emergent surgery 4 (10) 
Left main stenosis (n/%) 11 (28) 
Three vessel disease (n/%) 32 (80) 
Mild-moderate MR (n/%) 17 (43) 
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Table 2. Perioperative patient data presented as mean values ± standard deviation, unless 
otherwise indicated 
 
No. of grafts 3  ± 0.8 
Cross clamp time (minutes) 37 ± 12 
CPB time (minutes) 69 ± 28 
Inotropic support (n/%) 18 (45) 
ICU (days)* 2 (2/3) 
Mechanical ventilation (hours)* 8 (7/14) 
Complications (n/%)  
    Stroke 1 (3) 
   Periop. myocardial ischemia 5 (13) 
    Reexploration for  bleeding 2 (5) 
    Acute renal failure 2 (5) 
    Sternal wound infection 1 (3) 
    Prolonged mechanical  
    ventilation   (>72 hrs)                
3 (8) 
    IABP requirement 3 (8) 
Death (n/%) 2 (5) 
 
*Data as median and quartiles 
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Table 3. Longitudinal evolution of studied variables 
 
 
Variables 
 
T1 T2 T3 T4 
 
PLR 
mmol/min/m2 
 
0.033 
[-0.077/0.170] 
0.335 
[-0.285/0.973] 
0.465 
[0.113/0.922] 
0.421 
[-0.032/0.945] 
 
TPLG 
mmol/L 
 
0.014 
[-0.034/0.085] 
0.105 
[-0.102/0.279] 
0.163 
[0.041/0.249] 
0.120 
[-0.01/0.298] 
 
A-a O2 G 
kPa 
 
12.7 
[8.8/15] 
39.1 
[30.3/46.5] 
18.2 
[12.1/21.6] 
17.7 
[11.7/21.7] 
Systemic lactate 
mmol/L 
1.22  
[1/1.44] 
2.54  
[2.06/3.26] 
3.03  
[2.29/4.76] 
2.07  
[1.34/2.93] 
 
V-A dpCO2 
kPa 
 
0.6  
[0.5/0.9] 
0.6  
[0.4/0.8] 
0.9  
[0.7/1] 
0.7  
[0.5/1] 
 
PVR 
dyne·sec/cm5 
 
114  
[72/148] 
94  
[70/124] 
98  
[66/125] 
95  
[71/125] 
  
Data are shown as median with quartiles 
 
T1= Preoperative value 
T2= Value after discontinuation of CPB 
T3= Value 6 hrs postop 
T4= Value 18 hrs postop 
 
  
PLR = Pulmonary lactate release 
TPLG= Transpulmonary lactate gradient 
A-a  O2 G = Alveolar-arterial oxygen gradient 
V-A dpCO2 = Venoarterial pCO2 difference 
PVR = Pulmonary vascular resistance  
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Table 4. Clinical relevance of laboratory data tested with a nonparametric correlation analysis. 
Only correlations with a P < 0.05 are listed. 
Variables Spearman R Correlation P 
PLRT2 & A-a G O2 T2 0.39 0.012 
PLRT3 & A-a G O2 T4 0.48 0.002 
PLRT3 & LsT3 0.43 0.006 
PLRT4 & A-a G O2 T4 0.32 0.047 
PLRT4 & V-A dpCO2T4 0.37 0.019 
TPLGT2 & A-a G O2 T2 0.42 0.007 
TPLGT3 & A-a G O2 T4 0.52 0.001 
TPLGT3 & LsT3 0.43 0.006 
TPLGT4 & A-a G O2 T4 0.33 0.035 
TPLGT4 & LsT4 0.40 0.011 
TPLGT4 & V-A dpCO2T4 0.38 0.015 
A-a O2 GT1 & M.vent -0.46 0.003 
A-a O2 GT4 & CPB 0.34 0.029 
A-a O2 GT4 & PaCO2T4 -0.33 0.039 
A-a O2 GT4 & pHT4 0.33 0.035 
LsT2 & CPB 0.35 0.027 
LsT3 & CPB 0.45 0.004 
LsT3 & M.vent 0.44 0.004 
LsT4 & M.vent 0.51 0.001 
LsT4 & PVRT4 0.38 0.018 
PVRT4 & CPB 0.35 0.027 
V-A dpCO2T4 & CPB 0.44 0.005 
 
T1= Preoperative value 
T2= Value after discontinuation of CPB 
T3= Value 6 hrs postop 
T4= Value 18 hrs postop  
 
  
 
 
PLR = Pulmonary lactate release 
PaCO2 = Partial pressure of carbon dioxide  
A-a  O2 G = Alveolar-arterial oxygen gradient 
LS = Systemic arterial lactate 
TPLG= Transpulmonary lactate gradient 
V-A dpCO2 = Veno-arterial pCO2 difference 
M.vent = Duration of mechanical ventilation 
PVR = Pulmonary vascular resistance  
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